HIF1A and central nervous system cancer: In fact, it has been shown that PPAR-γ inhibition improves CIDEA expression, triggering glioma cell apoptosis and a decrease in HIF-1α activation, justifying further investigations aimed at evaluating the efficacy of PPAR-γ inhibitors as an effective anti-glioma therapeutic strategy [77].